Causes and Risk Factors of Leukemia

Leukemia is due to a series of mutations in genes that control the growth of cells, which leads to their uncontrolled growth in the bone marrow. While the exact causes of this are unknown, several risk factors for the disease have been identified.

Known risk factors vary with the different types of leukemia but include radiation (from atomic bomb exposures to medical radiation), exposures to chemicals such as benzene and pesticides, previous chemotherapy, some infections, and certain genetic conditions. There are others still under investigation as well, such as radon. 

Chronic leukemia is much more common in older adults, and though acute leukemia is often thought of as being a childhood cancer, acute myeloid leukemia is actually much more common in adults. For unknown reasons, men are more likely than women to develop the four major types of leukemia.

leukemia causes and risk factors
Illustration by Verywell

Confirmed and Probable Risk Factors

There are several risk factors for the development of leukemia that have been documented in a number of studies. A risk factor is something that is associated with an increased risk of developing leukemia but does not necessarily cause the disease. Some of these include:


Age as a risk factor for leukemia varies widely with the type of leukemia. Together, acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML) account for 30% of childhood cancers .

While many people consider these diseases pediatric cancers, AML is actually much more common in adults (the average age at diagnosis is 68).

Around 40 percent of cases of ALL are in adults; when diagnosed in childhood, it is most common in children under the age of 5 years.

Chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML) are much more common in older adults and are very uncommon in people under the age of 40.


The primary types of leukemia (AML, ALL, CML, and CLL) are slightly more common in males than females, but the reason for this is unknown.

Birth Weight

Children who have high birth weights (weight at birth greater than 8.9 pounds or 4000 grams) have a greater risk of developing ALL.


Racial differences in incidence differ between the types of leukemia.

ALL has the highest incidence in Hispanic whites, followed by non-Hispanic whites and Asian and Pacific Islanders, with the lowest incidence in blacks.

CLL is more common in non-Hispanic whites, followed by blacks, with the lowest incidence in Hispanics and Asian and Pacific Islanders.

AML is similar among people of different ethnic backgrounds during childhood, but in adults is more common in non-Hispanic whites.

CML is most common in non-Hispanic whites followed by blacks and then Hispanics, with the lowest incidence in Asian and Pacific Islanders.


Some types of radiation are known risk factors for leukemia, and others are only possible risk factors. There are two primary types of radiation:

  • Non-ionizing radiation: This type of radiation is fairly weak and includes the type that is emitted from a cell phone or computer terminal. While some concerns have been raised, such as the concern about brain tumor risk and cell phones, the risk is considered relatively small.
  • Ionizing radiation: In contrast, ionizing radiation has been linked to leukemia. This type of radiation has much more energy—enough to break certain chemical bonds, remove electrons from atoms, and damage DNA in cells.

There are a number of different ways in which ionizing radiation has been associated with leukemia. These include:

  • Atomic bomb radiation: Survivors of the Hiroshima and Nagasaki atomic bombings had a significantly increased risk of developing leukemia.
  • Nuclear accidents: Survivors of the 1986 Chernobyl nuclear reactor disaster had an increased risk of leukemia two to five years after the meltdown. Those who were highly exposed had twice the risk of developing leukemia as those not exposed.
  • Medical diagnostic radiation: Ionizing radiation was found to be carcinogenic (or cancer-causing) only a few years after X-rays were discovered, and concern has been raised in recent years over the danger of too much medical radiation, particularly in children. The risk varies, with imaging tests such as CT scans, bone scans, and PET scans involving much more radiation than plain X-rays. (MRI scans use magnets and do not involve exposure to radiation.)
  • Medical therapeutic radiation: Radiation therapy for cancer can increase the risk of developing leukemia (especially AML), with the risk highest in the period five to nine years after radiation. The risk varies with the site of radiation as well as the dose used.
  • Radioactive iodine therapy: Receiving radioactive iodine therapy as a treatment for hyperthyroidism or thyroid cancer is associated with an increased risk of leukemia, with the risk of AML being 80% higher than for those who didn't receive this therapy. The risk is even higher for CML, with those exposed having a risk 3.5 times higher than average.
  • Air and space travel: Air flight, especially over the far north, involves exposure to cosmic radiation, but this amount of ionizing radiation is relatively small. The leukemia risk from space travel due to galactic cosmic rays, however, is a subject of great interest among those looking at travel to places such as Mars in the future.
  • Radioactive materials: Uranium mining as an occupation increases the risk of leukemia. There has also been concern about exposure to radioactive material in tobacco products, which pick up these materials in the soil where they are grown.

Previous Chemotherapy

While the benefits of chemotherapy usually far outweigh the risks, some chemotherapy drugs can predispose a person to leukemia later on. This is true even for the drugs commonly used for early-stage breast cancer.

For most of these drugs, the risk begins to increase two years after treatment and peaks between five and 10 years after treatment. 

AML is the form of leukemia most often associated with chemotherapy, but ALL has also been linked to the treatment. Examples of drugs associated with leukemia include Cytoxan (cyclophosphamide); Leukeran (chlorambucil); VePesid (etoposide); Vumon (teniposide); Gleostine, CeeNu, and CCNSB (lomustine); Gliadel and BiCNU (carmustine); Myleran (busulfan); Mustargen (mechlorethamine); and Novantrone (mitoxantrone).

Drugs such as Adriamycin (doxorubicin) and other anthracyclines, Platinol (cisplatin) and other platinum drugs, and bleomycin have been associated with leukemia but less commonly than the drugs mentioned earlier.

Medical Conditions

Some medical conditions are associated with an elevated risk of developing leukemia. Myelodysplastic syndromes are disorders of the bone marrow that have been referred to as "preleukemia" and carry a significant risk of developing into AML (up to 30%). Other conditions such as essential thrombocytopenia, primary myelofibrosis, and polycythemia vera also carry an increased risk.

Furthermore, people who are immunosuppressed, such as those who take immunosuppressive medications due to an organ transplant, have a significantly increased risk of developing leukemia.

Associations have been noted between leukemia in adults and medical conditions such as inflammatory bowel disease (ulcerative colitis and Crohn's disease), rheumatoid arthritis, systemic lupus erythematosus (lupus), celiac disease, and pernicious anemia, among others. However, a large 2012 study looking into these associations only found an increased risk relationship with ulcerative colitis and AML, and peptic ulcer disease and CML.

Genetic syndromes may also increase the risk of leukemia (see below).


Adding to the list of cancers caused by smoking, tobacco use is associated with a significantly increased risk of AML.

At the current time, it's thought that around 20 percent of AML cases are linked to smoking.

There is some evidence that leukemia in children may be linked with parent's smoking, and mothers exposed to secondhand smoke appear to have a slightly elevated risk of developing ALL.

Home and Occupational Exposures

There are a number of exposures that have been associated with leukemia, though the risk varies with the different types of the disease. Some of the substances have been linked clearly in many studies, while others are still uncertain. Some exposures of interest include:

  • Benzene: Benzene is a known carcinogen that is present in a number of materials, such as some paints, solvents, plastics, pesticides, detergents, and unleaded gasoline. Benzene is also a byproduct of the combustion of coal. Benzene in tobacco smoke is thought to be one of the reasons why smoking is strongly linked to AML. Maternal and childhood exposure to paint at home is associated with an elevated risk of ALL. Home use of petroleum solvents is associated with an increased risk of childhood AML. 
  • Home pesticide exposures: Pesticide exposure during pregnancy and childhood appears to be associated with an increased risk of leukemia, according to several studies.
  • Contaminated drinking water: An increased risk of leukemia was found among those at a U.S. Marine Corp base camp in North Carolina that was contaminated by a solvent between 1950 and 1985.
  • Formaldehyde: Medical workers and embalmers have an increased risk of myeloid leukemias. While exposure is common in these workers, but many people are exposed to formaldehyde through the "off-gassing" of formaldehyde from pressed wood products (such as particleboard, plywood, and fiberboard). Formaldehyde exposure such as this is considered to be a known carcinogen, but it's not clear what level of exposure (amount or duration) might be a problem. Other sources of formaldehyde include some glues and adhesives, some insulation materials, and some paper product coatings. Like benzene, formaldehyde is also found in tobacco smoke.

Noting that the incidence of childhood leukemia has been increasing in California, studies looking at environmental exposures that may be associated with this risk are in progress.


Infection with the human T-cell leukemia virus (HTLV-1) increases the risk of leukemia. The virus is a retrovirus (similar to HIV) and infects the type of white blood cells known as T lymphocytes or T cells. HTLV-1 is spread in a way similar to HIV; it can be transmitted through blood transfusions, through sexual contact, by sharing needles among IV drug abusers, and from a mother to a child during delivery or through breastfeeding.

HTLV-1 is relatively uncommon in the United States, but is found in the Caribbean (especially Haiti and Jamaica), Japan, central and west Africa, and Middle East (especially Iran). It's thought that between 1 and 4% of people who are exposed to the virus will develop leukemia; the most common age of onset is between 30 and 50.


While alcohol consumption is linked with a number of cancers, a 2014 study found no association between alcohol use and the four major types of leukemia. There has been a link noted, however, between maternal alcohol consumption during pregnancy and AML in children born to these mothers. 

Possible Risk Factors

In addition to known and probable risk factors for leukemia, there are several risk factors that are being evaluated for their association with leukemia. Some possible risk factors include:

Western Diet

With many types of leukemia, especially acute leukemia in children, there appears to be little association with dietary practices. In CLL, however, the most common type of leukemia in American adults, diet may play a role.

A 2018 study in Spain found that those who ate a Western diet were 63 percent more likely to develop CLL than those who consumed a Prudent diet or Mediterranean diet.


There has been controversy surrounding a possible connection between the artificial sweetener sucralose and cancer.

Sucralose (with brand names including Splenda and others) was approved in 1999 and is currently in thousands of products worldwide.

Despite a multitude of reassuring studies prior to its approval, a 2016 Italian study on mice found that rodents who were exposed to sucralose throughout their lives (beginning in utero) had a significantly increased risk of developing leukemia.

It's important to note that this was an animal study, and the doses given were equivalent to an adult consuming four times the average amount of sucralose every single day. That said, with the popularity of sucralose as a sugar substitute, it's thought that young children could easily exceed the FDA's acceptable daily intake of 5 mg/kg daily.

(Keep in mind that, despite a focused concern about sucralose, questions have been raised about the use of other artificial sweeteners as well. Ideally, any of these products should be used sparingly in a healthy diet.)

Electromagnetic Fields (Power Lines)

Since 1979, when a study found an increased risk of leukemia in children who lived near high voltage power lines, a number of studies have looked at this possible association with mixed results. Some showed an increased risk with high levels of exposure, and others showed little, if any, effect.

Three analyses that have compared results of studies to date (totaling 31 studies in all) found that high exposures (0.3 uT or higher) were associated with a 1.4 to 2.0 times increased risk of leukemia. This level of exposure, however, is not common. In these studies, only 0.5 to 3.0% of children had an exposure equal to or exceeding 0.3 uT.


At the current time, there is a possibility that radon in homes, a form of ionizing radiation, may increase the risk of chronic lymphocytic leukemia (CLL).

Radon is a well-known carcinogen, and it's thought that roughly 27,000 people die from radon-induced lung cancer each year in the United States. 

Radon is an odorless, colorless gas, that is produced by the normal breakdown of uranium found in the soil and rocks beneath homes. Elevated levels have been found in all 50 states, and the only way to know if you are at risk is to do radon testing.

A 2016 study found that the areas in the United States where CLL is most common are also the regions known to have the highest radon levels (northern and central states). While the association between radon and leukemia is uncertain, some researchers propose that radon could lead to leukemia in a way similar to how it increases lung cancer risk.

Coffee and Tea

Coffee and tea have both been looked at with regard to the risk of leukemia, and the studies have been mixed. Some indicated an increased risk with more consumption, while others instead showed a potential protective effect (a reduced risk of leukemia). Since people metabolize coffee and tea in different ways (fast metabolizers vs. slow metabolizers), it could be that the effects vary between different people.

Sedentary Lifestyle

While some studies have found no association between level of physical activity and leukemia, a 2016 study found that people who engaged in more "leisure physical activity" were around 20% less likely to develop myeloid leukemias than those who were less active.


The role of family history and genetics varies between the different types of leukemia.

ALL does not appear to run in families, with the exception being identical twins, in which one of the siblings in the pair has an increased risk of developing ALL if the other developed the disease before one year of age. That said, there are certain genetic syndromes that are associated with an increased risk of this type of leukemia (see below).

In contrast, family history plays an important role in CLL.

People who have a first-degree family member who has had CLL (parent, sibling, or child) have more than twice the risk of developing the disease themselves. 

A family history of AML in first-degree relatives increases risk, but the age at diagnosis is important. Siblings of children with AML have up to a four times higher risk of developing the disease, with the risk in identical twins being around 20%. In contrast, children who have a parent who has adult-onset leukemia do not appear to be at a higher risk.

Family history doesn't appear to play a significant role in the development of CML.

Genetic conditions and syndromes that are associated with an increased risk of some types of leukemia include:

  • Down syndrome (trisomy 21): People with Down syndrome have roughly a 20% increased risk of developing leukemia (AML and ALL). The incidence is highest in children under the age of 5 years.
  • Klinefelter's syndrome (XXY)
  • Fanconi anemia
  • Li-Fraumeni syndrome
  • Neurofibromatosis
  • Ataxia telangiectasia
  • Bloom syndrome
  • Wiskott Aldrich syndrome
  • Schwachman-Diamond syndrome
  • Blackfan-Diamond syndrome
  • Kostmann syndrome

Frequently Asked Questions

  • What are the risk factors for childhood leukemia?

    Some of the risk factors for leukemia in childhood include:

    • Genetic disorders, such as Down syndrome
    • Inherited immune problems, such as ataxia-telangiectasia
    • Having a sibling, particularly a twin, with leukemia
    • High levels of radiation exposure
    • Certain chemotherapy drugs, including cyclophosphamide, doxorubicin, teniposide, and etoposide
  • What are the symptoms of leukemia?

    Symptoms of leukemia can depend on the type of leukemia you have. Some of the common signs and symptoms include:

    • Feeling tired easily
    • Fever
    • Easy bruising and bleeding
    • Swollen lymph nodes
    • Frequent infections
    • Unexplained weight loss
    • Bone or joint pain
53 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Puckett Y, Chan O. Cancer, Acute Lymphocytic Leukemia (ALL) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from:

  2. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician; 89(9):731-8.

  3. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review [published correction appears in Environ Health Perspect. 2010 Sep;118(9):A380]. Environ Health Perspect. 2007;115(1):138–145. doi:10.1289/ehp.9023

  4. Payandeh M, Sadeghi E, Khodarahmi R, Sadeghi M. Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)Int J Hematol Oncol Stem Cell Res; 8(4):49–53.

  5. Jackson N, Menon BS, Zarina W, Zawawi N, Naing NN. Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes. Ann Hematol; 78(5):233-6.

  6. McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS. Birth weight, maternal weight and childhood leukaemiaBr J Cancer. 2006;94(11):1738–1744. doi:10.1038/sj.bjc.6603173

  7. Elo IT, Preston SH. Racial and Ethnic Differences in Mortality at Older Ages. In: National Research Council (US) Committee on Population; Martin LG, Soldo BJ, editors. Racial and Ethnic Differences in the Health of Older Americans. Washington (DC): National Academies Press (US). 2. Available from:

  8. Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic malignanciesBlood. 2017;130(15):1699–1705. doi:10.1182/blood-2017-04-778225

  9. Lee JP, Birnstein E, Masiello D, Yang D, Yang AS. Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective studyJ Hematol Oncol. 2009;2:30. Published 2009 Jul 24. doi:10.1186/1756-8722-2-30

  10. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Non-Ionizing Radiation, Part 2: Radiofrequency Electromagnetic Fields. Lyon (FR): International Agency for Research on Cancer. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 102.) 2. Cancer in Humans. Available from:

  11. Richardson DB, Wing S, Schroeder J, Schmitz-Feuerhake I, Hoffmann W. Ionizing radiation and chronic lymphocytic leukemiaEnviron Health Perspect. 2005;113(1):1–5. doi:10.1289/ehp.7433

  12. Jordan BR. The Hiroshima/Nagasaki Survivor Studies: Discrepancies Between Results and General PerceptionGenetics. 2016;203(4):1505–1512. doi:10.1534/genetics.116.191759

  13. Zablotska LB. 30 years After the Chernobyl Nuclear Accident: Time for Reflection and Re-evaluation of Current Disaster Preparedness PlansJ Urban Health. 2016;93(3):407–413. doi:10.1007/s11524-016-0053-x

  14. Möhner M, Gellissen J, Marsh JW, Gregoratto D. Occupational and diagnostic exposure to ionizing radiation and leukemia risk among German uranium miners. Health Phys; 99(3):314-21.

  15. Ron E. Cancer risks from medical radiation. Health Phys; 85(1):47-59.

  16. Molenaar RJ, Sidana S, Radivoyevitch T, et al. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer. J Clin Oncol; 36(18):1831-1839.

  17. Kim MH, Rusek A, Cucinotta FA. Issues for Simulation of Galactic Cosmic Ray Exposures for Radiobiological Research at Ground-Based AcceleratorsFront Oncol. 2015;5:122. Published 2015 Jun 4. doi:10.3389/fonc.2015.00122

  18. Durakovic A. Medical effects of internal contamination with actinides: further controversy on depleted uranium and radioactive warfareEnviron Health Prev Med. 2016;21(3):111–117. doi:10.1007/s12199-016-0524-4

  19. Godley LA, Larson RA. Therapy-related myeloid leukemiaSemin Oncol. 2008;35(4):418–429. doi:10.1053/j.seminoncol.2008.04.012

  20. Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemiaSemin Oncol. 2013;40(6):666–675. doi:10.1053/j.seminoncol.2013.09.013

  21. Traversa G, Menniti-ippolito F, Da cas R, Mele A, Pulsoni A, Mandelli F. Drug use and acute leukemia. Pharmacoepidemiol Drug Saf; 7(2):113-23.

  22. Albitar M, Manshouri T, Shen Y, et al. Myelodysplastic syndrome is not merely "preleukemia". Blood; 100(3):791-8.

  23. Wiseman AC. Immunosuppressive MedicationsClin J Am Soc Nephrol. 2016;11(2):332–343. doi:10.2215/CJN.08570814

  24. Johnson KJ, Blair CM, Fink JM, et al. Medical conditions and risk of adult myeloid leukemia. Cancer Causes Control; 23(7):1083-9.

  25. Kane EV, Roman E, Cartwright R, Parker J, Morgan G. Tobacco and the risk of acute leukaemia in adultsBr J Cancer. 1999;81(7):1228–1233. doi:10.1038/sj.bjc.6690833

  26. Metayer C, Petridou E, Aranguré JM, et al. Parental Tobacco Smoking and Acute Myeloid Leukemia: The Childhood Leukemia International ConsortiumAm J Epidemiol. 2016;184(4):261–273. doi:10.1093/aje/kww018

  27. Tsai RJ, Luckhaupt SE, Schumacher P, Cress RD, Deapen DM, Calvert GM. Acute myeloid leukemia risk by industry and occupationLeuk Lymphoma. 2014;55(11):2584–2591. doi:10.3109/10428194.2014.894189

  28. Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysisEnviron Health. 2010;9:31. Published 2010 Jun 28. doi:10.1186/1476-069X-9-31

  29. Hernández AF, Menéndez P. Linking Pesticide Exposure with Pediatric Leukemia: Potential Underlying Mechanisms. Int J Mol Sci; 17(4):461.

  30. Bove FJ, Ruckart PZ, Maslia M, Larson TC. Evaluation of mortality among marines and navy personnel exposed to contaminated drinking water at USMC base Camp Lejeune: a retrospective cohort studyEnviron Health. 2014;13(1):10. Published 2014 Feb 19. doi:10.1186/1476-069X-13-10

  31. Zhang L, Freeman LE, Nakamura J, et al. Formaldehyde and leukemia: epidemiology, potential mechanisms, and implications for risk assessmentEnviron Mol Mutagen. 2010;51(3):181–191. doi:10.1002/em.20534

  32. Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res; 681(2-3):150-68.

  33. Giddings BM, Whitehead TP, Metayer C, Miller MD. Childhood leukemia incidence in California: High and rising in the Hispanic populationCancer. 2016;122(18):2867–2875. doi:10.1002/cncr.30129

  34. Gonçalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseasesClin Microbiol Rev. 2010;23(3):577–589. doi:10.1128/CMR.00063-09

  35. Rota M, Porta L, Pelucchi C, et al. Alcohol drinking and risk of leukemia-a systematic review and meta-analysis of the dose-risk relation. Cancer Epidemiol; 38(4):339-45.

  36. Solans M, Castelló A, Benavente Y, et al. Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica; 103(11):1881-1888.

  37. Berry C, Brusick D, Cohen SM, Hardisty JF, Grotz VL, Williams GM. Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory RationaleNutr Cancer. 2016;68(8):1247–1261. doi:10.1080/01635581.2016.1224366

  38. M S, M P, E T, et al. Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice. Int J Occup Environ Health; 22(1):7-17.

  39. Kheifets L, Crespi CM, Hooper C, et al. Epidemiologic study of residential proximity to transmission lines and childhood cancer in California: description of design, epidemiologic methods and study populationJ Expo Sci Environ Epidemiol. 2015;25(1):45–52. doi:10.1038/jes.2013.48

  40. Schwartz GG, Klug MG. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels. Future Oncol; 12(2):165-74.

  41. Ugai T, Matsuo K, Sawada N, et al. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan. Int J Cancer; 142(6):1130-1138.

  42. Moore SC, Lee I, Weiderpass E, et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million AdultsJAMA Intern Med; 176(6):816–825. 

  43. Iacobucci I, Mullighan CG. Genetic Basis of Acute Lymphoblastic Leukemia. J Clin Oncol; 35(9):975-983.

  44. Lagunas-Rangel FA, Chávez-Valencia V, Gómez-Guijosa MÁ, Cortes-Penagos C. Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis. Int J Hematol Oncol Stem Cell Res; 11(4):328–339.

  45. Porter CC. Germ line mutations associated with leukemiasHematology Am Soc Hematol Educ Program. 2016;2016(1):302–308. doi:10.1182/asheducation-2016.1.302

  46. Khan I, Malinge S, Crispino J. Myeloid leukemia in Down syndromeCrit Rev Oncog; 16(1-2):25–36.

  47. Horsman DE, Pantzar JT, Dill FJ, Kalousek DK. Klinefelter's syndrome and acute leukemia. Cancer Genet Cytogenet; 26(2):375-6.

  48. Alter BP. Fanconi anemia and the development of leukemiaBest Pract Res Clin Haematol. 2014;27(3-4):214–221. doi:10.1016/j.beha.2014.10.002

  49. Swaminathan M, Bannon SA, Routbort M, et al. Hematologic malignancies and Li-Fraumeni syndrome. Cold Spring Harb Mol Case Stud; 5(1)

  50. Stiller CA, Chessells JM, Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG studyBr J Cancer. 1994;70(5):969–972. doi:10.1038/bjc.1994.431

  51. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphomaJ Clin Pathol. 2001;54(7):512–516. doi:10.1136/jcp.54.7.512

  52. American Cancer Society. Risk factors for childhood leukemia.

  53. Cleveland Clinic. Leukemia.

Additional Reading

By Karen Raymaakers
Karen Raymaakers RN, CON(C) is a certified oncology nurse that has worked with leukemia and lymphoma patients for over a decade.